Identification of inheritance modes of mitochondrial diseases by introduction of pure nuclei from mtDNA-less HeLa cells to patient-derived fibroblasts.
A nuclear genome delivery system was developed to deduce the modes of inheritance of the clinical phenotypes observed in patients with mitochondrial diseases by transfer of pure nuclei from normal cells to fibroblasts from the patients. The problem of possible contamination of the nuclei with a small amount of mtDNA was overcome by using mtDNA-less (rho0) human cells as nuclear donors. In this study, intercellular transfer of pure nuclei was carried out by simple fusion of rho0 HeLa cells with 533 fibroblasts from a patient with a fatal mitochondrial disease, which were deficient in cytochrome c oxidase and succinate dehydrogenase activities. The results showed that the cytochrome c oxidase and succinate dehydrogenase activities were restored by the introduction of pure HeLa nuclei, suggesting that the observed phenotypes of mitochondrial dysfunction were not due to mtDNA mutations but to nuclear, recessive mutations. Thus, our nuclear transfer system is effective for determining whether a mitochondrial or nuclear genome of a patient is responsible for a disease and whether deficiency of mitochondrial enzymes, including enzymes exclusively encoded by nuclear genomes, is transmitted in a nuclear recessive or nuclear dominant way, providing the parents of the patients with valuable information for genetic counseling on the risk of mitochondrial diseases in their next babies.
Isobe
K
K
Institute of Biological Sciences, University of Tsukuba, Ibaraki 305, Japan.
Kishino
S
S
Inoue
K
K
Takai
D
D
Hirawake
H
H
Kita
K
K
Miyabayashi
S
S
Hayashi
J I
JI
D000251:Adenosine Triphosphatases / Q000378:metabolism; D002467:Cell Nucleus; D030401:Cytochrome-c Oxidase Deficiency; D004272:DNA, Mitochondrial / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005347:Fibroblasts / Q000166:cytology; D006367:HeLa Cells; D006801:Humans; D007223:Infant; D017240:Mitochondrial Myopathies / Q000235:genetics*; D009840:Oligomycins / Q000494:pharmacology; D013385:Succinate Dehydrogenase / Q000172:deficiency
D004272:DNA, Mitochondrial; D004791:Enzyme Inhibitors; D009840:Oligomycins; D013385:Succinate Dehydrogenase; D000251:Adenosine Triphosphatases